Like Applied Maths

closed 1/5/2016 via BNC Analysis

bioMérieux S.A., acquired Applied Maths

synopsis: bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
buyer: bioMérieux S.A. (:$1,996.55)
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. "
target: Applied Maths
Applied Maths develops cutting-edge software for the biosciences. The company has gained worldwide recognition with its software GelCompar for the analysis of 1D gel patterns, and later even more with BioNumerics, a software suite for integrated databasing and analysis of biological data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/28/2013 via Company Press Release

Illumina, Inc., acquired NextBio, Inc.

synopsis: Illumina, Inc. has acquired Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. They provide innovative sequencing and array-based solutions. "
target: NextBio, Inc.
NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/11/2021 via BusinessWire

Komodo Health Inc., acquired Mavens

synopsis: Komodo Health has announced its acquisition of Mavens, the pioneer in building trusted software products and implementing cloud-based technology to help biotech, rare disease, and specialty pharma companies navigate the challenges of commercialization.
buyer: Komodo Health Inc.
At Komodo Health, they partner with their customers to improve patient care and reduce disease burden through data-driven insights. The Komodo Health Platform delivers patient-level insights by dynamically analyzing the broadest array of data across patients, practitioners, and health systems. "
target: Mavens
Mavens is the pioneer in building trusted software products and implementing cloud-based technology to help biotech, rare disease, and specialty pharma companies navigate the challenges of commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/12/2018 via BusinessWire

Medidata Solutions Worldwide, will acquire SHYFT Analytics

synopsis: Medidata announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. "
target: SHYFT Analytics
SHYFT Analytics is the leading cloud data analytics platform for life sciences with solutions designed exclusively for the pharmaceutical and biotech industry.
price ($mm)
$195
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2011 via BusinessWire

PerkinElmer, Inc., acquired Geospiza

synopsis: PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has acquired Geospiza, Inc., a leading developer of software systems for the management of genetic analysis and laboratory workflows delivered through a Web-based secure cloud computing environment.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Geospiza
Designed by biologists for biologists, Geospiza is the developer of GeneSifter® software, providing integrated solutions for Next Generation Sequencing analysis and LIMS. Geospiza has set the industry standard for high value, low cost, “out of the box” solutions serving the life sciences market.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/23/2021 via PR Newswire

InsightfulScience, will acquire Dotmatics

synopsis: Insightful Science, a leading software provider, will acquire UK-based Dotmatics, an industry leading cloud-based scientific R&D data management platform. By integrating Insightful Science's software applications into Dotmatics cloud-first enterprise data management solution, the company will provide an end-to-end scientific research platform.
buyer parent: Insight Venture Partners
buyer: InsightfulScience
Insightful Science is a life sciences software company that digitally connects researchers to their ideas and data. The company empowers life sciences researchers to plan effective experiments, connect with data, and extract insights so they can produce life-changing outcomes. "
target parent: Scottish Equity Partners
target: Dotmatics
UK-based Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research—accelerating the journey towards full digitalization and the Lab of the Future.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2019 via PR Newswire

GraphPad Software, Inc., acquired SnapGene

synopsis: GraphPad Software, the leading provider of software developed exclusively for the scientific community, announced it has acquired SnapGene, a leading bioinformatics software solution that provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures.
buyer: GraphPad Software, Inc.
GraphPad is the leading provider of software developed exclusively for the scientific community. GraphPad Prism, their flagship product, is the preferred analysis and graphing solution for scientific research. Prism helps scientists discover and share the story in their data. "
target: SnapGene
SnapGene was founded by scientists and software designers to meet the everyday needs of molecular biologists. Their software provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/16/2012 via BusinessWire

Tegal Corporation, acquired CollabRX, Inc

synopsis: Tegal Corporation announced the closing of a transaction to acquire CollabRx, Inc., a privately held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine.
buyer: Tegal Corporation (TGAL:$0.02)
Tegal Corporation's legacy is evident in the most advanced consumer and industrial products that incorporate microprocessors, magnetic memories, radio frequency ID chips, acoustic wave devices, sensors, LEDs, and an array of other semiconductor and MEMS devices. "
target: CollabRX, Inc (CM:CLRX:$0.38)
CollabRx offers cloud-based expert systems that provide clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision making.
price ($mm)
$1.35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/11/2019 via PR Newswire

InVitae, will acquire Jungla Inc.

synopsis: Invitae, a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare, will acquire Jungla, an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests.
buyer: InVitae (NVTA:$216.82)
Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare. They aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Jungla Inc.
Jungla Inc. is an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests. Jungla's technologies combine advances in functional genomics, computational biophysics, cellular engineering, and computer science.
price ($mm)
$50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2019 via PR Newswire

Beckman Coulter, Inc, acquired Cytobank

synopsis: Beckman Coulter, a company that is advancing healthcare to enhance the diagnostic laboratory’s role in improving healthcare outcomes, announced its acquisition of Cytobank, a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research.
buyer parent: Danaher Corporation
buyer: Beckman Coulter, Inc (BEC:$3,260.60)
Beckman Coulter is committed to advancing healthcare by applying science, technology and the creativity of their teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Their diagnostic systems are used in complex biomedical testing and are found around the globe. "
target: Cytobank
Cytobank Inc. is a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research. Pharmaceutical, biotechnology, and academic researchers around the world use their SaaS solution to develop deep understandings of complex biology at the single cell level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2020 via BusinessWire

Illumina, Inc., acquired BlueBee

synopsis: Illumina, Inc. is acquiring BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina, Inc. is a biotechnology company. They provide sequencing and array-based solutions for genetic analysis. Their studies help accelerate the studies of personalized medicine and their products are used for applications in life sciences and other emerging health segments. "
target: BlueBee
BlueBee is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/26/2005 via PR Newswire

Entelos Inc., acquired Discovery Innovations, Inc.

synopsis: Entelos, Inc., the leader in biosimulation technologies for pharmaceutical research and development, announced today the acquisition of Discovery Innovations, a specialized provider of data integration products and services to the life sciences.
buyer: Entelos Inc.
Entelos partners with pharmaceutical and biotech organizations worldwide to develop effective new treatments for disease and dramatically reduce the time and cost needed to develop them. Using our patented PhysioLab technology, Entelos develops dynamic large-scale computer models of human disease. "
target: Discovery Innovations, Inc.
Discovery Innovations is a specialized provider of web-based products and information services to the life sciences. Recognizing the tidal wave of information being generated in the life sciences, Discovery Innovations has developed products and services that more efficiently access, deliver and sha
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2021 via BNC Analysis

Immunai, acquired Dropprint Genomics

synopsis: Immunai, a biotech company using single-cell biology and AI to power new therapeutic discoveries, has acquired Dropprint Genomics, a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning.
buyer: Immunai
Immunai is a biotech company using single-cell biology and AI to power new therapeutic discoveries. Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries. "
target: Dropprint Genomics
Dropprint Genomics is a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning. Their technology identifies gene data sets to help users better understand the immune system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/25/2019 via PR Newswire

GraphPad Software, Inc., will acquire Geneious

synopsis: GraphPad, a leading provider of data analysis and visualization software for the life sciences industry, announced today that it will acquire Biomatters, a leading provider of Geneious DNA data analysis solutions.
buyer: GraphPad Software, Inc.
GraphPad is the leading provider of software developed exclusively for the scientific community. GraphPad Prism, their flagship product, is the preferred analysis and graphing solution for scientific research. Prism helps scientists discover and share the story in their data. "
target: Geneious
Biomatters, dba Geneious, empowers its customers with software that transforms biological data into insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering and advanced comparative analysis of DNA, RNA and protein sequences.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/10/2020 via PR Web

HealthLytix merged with Cortechs Labs Inc,

synopsis: CorTechs Labs Inc., the leading quantitative neuroimaging software company, announced that it has merged with sister company HealthLytix, a healthcare technology company developing new applications in genetics and medical imaging to improve the screening and early detection of cancer and neurodegenerative diseases.
buyer: Cortechs Labs Inc
CorTechs Labs is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so people can enjoy longer, better lives. "
target: HealthLytix
HealthLytix is a precision health company and developer of quantitative medical imaging solutions that leverage machine learning. HealthLytix creates data analytics solutions to provide comprehensive insights into health status based on genetics, quantitative imaging, and other medical information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2017 via PR Newswire

InVitae, acquired CancerGene Connect

synopsis: Invitae Corporation, one of the fastest growing genetic information companies, has acquired Ommdom Inc., which develops healthcare software, including CancerGene Connect, one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories.
buyer: InVitae (NVTA:$216.82)
Invitae is one of the fastest growing genetic information companies in the U.S. Invitae Corporation's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. "
target: CancerGene Connect
CancerGene Connect is one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories. CancerGene Connect was developed by clinicians for clinicians to streamline the collection, analysis, and management of patient family history information.
price ($mm)
$6.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2014 via PR Newswire

Roche Ltd, acquired Bina Technologies

synopsis: Bina Technologies, Inc. announced that they have been acquired by Roche. Bina Technologies is a privately held company that provides a big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and translational research markets. Bina will be integrated into the Roche Sequencing Unit.
buyer: Roche Ltd
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. "
target: Bina Technologies
Bina Technologies builds technologies for scalable and accurate processing and management of genomic information. Bina's Genomic Management Solution is an integrated and scalable analysis platform that empowers clinical and translational researchers to gain insight from their genomic data sets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2016 via PR Newswire

Sunquest Information Systems, acquired UNIConnect LC

synopsis: Provider of diagnostics informatics solutions to more than 1,700 laboratories, Sunquest Information Systems, Inc. announced the acquisition of the Salt Lake City-based software firm UNIConnect® L.C. UNIConnect specializes in software for molecular laboratories and augments Sunquest's molecular diagnostics solution.
buyer parent: Roper Technologies, Inc.
buyer: Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostics informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world optimize financial results, enhance efficiency and improve the quality of patient care. "
target: UNIConnect LC
Based in Salt Lake City, UT, UNIConnect® L.C. has created a Laboratory Information Management System (LIMS) platform that marries breakthrough software technology with unparalleled customization and configuration control to advance the "omic" sciences and precision medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/5/2016 via BNC Analysis

bioMérieux S.A., acquired Applied Maths

synopsis: bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
buyer: bioMérieux S.A. (:$1,996.55)
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. "
target: Applied Maths
Applied Maths develops cutting-edge software for the biosciences. The company has gained worldwide recognition with its software GelCompar for the analysis of 1D gel patterns, and later even more with BioNumerics, a software suite for integrated databasing and analysis of biological data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/5/2016 via BNC Analysis

bioMérieux S.A., acquired Applied Maths

synopsis: bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
buyer: bioMérieux S.A. (:$1,996.55)
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. "
target: Applied Maths
Applied Maths develops cutting-edge software for the biosciences. The company has gained worldwide recognition with its software GelCompar for the analysis of 1D gel patterns, and later even more with BioNumerics, a software suite for integrated databasing and analysis of biological data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2004 via BusinessWire

Apogent Technologies, Inc. merged with Fisher Scientific International Inc.,

synopsis: Fisher Scientific International Inc. (NYSE: FSH) today completed its approximately $4.0 billion merger with Apogent Technologies Inc. (formerly trading as NYSE: AOT), providing Fisher Scientific with a $1.1 billion footprint in the high-growth life-science market.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Fisher Scientific International Inc.
Fisher Scientific International, Inc. provides products and services to the scientific research and clinical laboratory markets. It operates in three segments: Scientific Products and Services, Healthcare Products and Services, and Laboratory Workstations. The Scientific Products and Services segmen"
target: Apogent Technologies, Inc.
Apogent Technologies Inc. is a developer and manufacturer of value-added products for the clinical and research markets. Over 80% of the Company's products are consumables. Apogent's operating subsidiaries manufacture most of their products in approximately 80 facilities worldwide. The Company's cu
price ($mm)
$3,991
rev ($mm)
$1,118
EBITDA ($mm)
$313
EV / rev
3.6x
EV / EBITDA
12.7x
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
announced 1/13/2020 via GlobeNewswire

TelaDoc, Inc., will acquire InTouch Health

synopsis: Teladoc Health, Inc., the global leader in virtual care, will acquire InTouch Health, the leading provider of enterprise telehealth solutions for hospitals and health systems. This acquisition positions Teladoc Health as the partner of choice for health systems seeking a single solution for their entire virtual care strategy.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is transforming the healthcare experience with a focus on high quality, lower costs, and improved outcomes. Telehealth Satisfaction Study, the integrated services from Teladoc Health include telehealth, expert medical services, AI and analytics, and licensable platform services. "
target parent: Galen Partners
target: InTouch Health
InTouch Health is a telehealth services company that offers healthcare providers a reliable, dedicated cloud-based network and virtual care solutions to efficiently deliver care for a broad array of use cases and healthcare environments.
price ($mm)
$600
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/27/2009 via Reuters

The Carlyle Group, will acquire Broadleaf Co., Ltd.

synopsis: Private equity firm The Carlyle Group announced that it has agreed to purchase Broadleaf Co, a Japanese maker of software for car maintenance facilities. This is the first buyout for Carlyle in Japan since it bought LCD glass maker AvanStrate Inc.
buyer: The Carlyle Group (CG:$6,117.50)
The Carlyle Group is a private global investment firm that originates, structures and acts as lead equity investor in management-led buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. "
target parent: Olympus Corporation
target: Broadleaf Co., Ltd.
Broadleaf Co. is involved in the development, sale, and support of various software packages for the automotive industry, including the Super Frontman automobile maintenance system, administrative system packages for inventory control, customer control, and estimate/sales/billing control.
price ($mm)
$212
rev ($mm)
$181
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/22/2005 via BNC Analysis

Clinical Data, Inc., will acquire Genaissance Pharmaceuticals, Inc.

synopsis: Clinical Data Inc. announced Tuesday that it will acquire Genaissance Pharmaceuticals in an all-stock transaction valued at $56 million. Genaissance shareholders will own 40 percent of the combined company when the deal closes sometime in the fourth quarter.
buyer: Clinical Data, Inc. (CLDA:$0.00)
Clinical Data, Inc. provides a full range of products and services to the growing domestic Physician Office Laboratory market and to smaller laboratories internationally & also provides a complete range of products and services for the Physician Office Laboratory and hospital laboratory market. "
target: Genaissance Pharmaceuticals, Inc.
Genaissance is a world leader in the discovery and use of human gene variation for the development of a new generation of DNA-based diagnostic and therapeutic products. Genaissance markets its technology, clinical development skills and Pharmacogenomic support services to the pharmaceutical industr
price ($mm)
$56
rev ($mm)
$21
EBITDA ($mm)
EV / rev
2.7x
EV / EBITDA
announced 8/5/2020 via GlobeNewswire

Livongo will be merged with TelaDoc, Inc.,

synopsis: Teladoc Health, the global leader in virtual care, and Livongo, the leading Applied Health Signals company, have entered into a definitive merger agreement. The combination of Teladoc Health and Livongo will create a global leader in consumer centered virtual care. The combined company will operate under the Teladoc Health brand.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is recognized as the world leader in virtual care. They deliver millions of medical visits across 175 countries annually through the Teladoc Health Medical Group, enabling millions of patient and provider touchpoints for hospitals, health systems, and physician practices globally. "
target: Livongo (LVGO:$257.96)
Livongo empowers people with chronic conditions to live better and healthier lives. Using its AI+AI engine, Livongo aggregates and interprets health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them.
price ($mm)[EV]
$16,988 [$16,567]
rev ($mm)
$258
EBITDA ($mm)
EV / rev
70.8x
EV / EBITDA
announced 6/3/2020 via BusinessWire

BreathResearch will be merged with AireHealth,

synopsis: AireHealth Inc., a company that offers affordable treatments, symptom tracking and early detection of respiratory conditions, has reached a merger agreement with BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status.
buyer: AireHealth
AireHealth offers affordable treatments, symptom tracking and early detection of respiratory conditions. The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. "
target: BreathResearch
BreathResearch is an innovative healthcare company that offers a solution that converts the air waves from breathing into sound waves producing new respiratory analytics to improve health, fitness and performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/14/2018 via BNC Analysis

MindMaze, acquired Neuro Motor Innovations Corporation

synopsis: MindMaze, operator of a platform that captures brain activity announced its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI). NMI is a medical technology company with a mission to improve movement and cognition outcomes through their brain repair therapy.
buyer: MindMaze
MindMaze operates a platform that captures brain activity, creating a new operating system for computers - a brain O/S. They designed an intuitive mind/machine interface, which utilizes pre-realtime decoding of brain signals via neural prediction, transforming healthcare and gaming industries. "
target: Neuro Motor Innovations Corporation
Neuro Motor Innovations (NMI) is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients. NMI’s solution includes a proprietary medical gaming platform, game therapy software, and hardware control devices for hand, arm, foot and face.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via GlobeNewswire

BioTelemetry, acquired Telcare

synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer: BioTelemetry (BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
target: Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/26/2010 via Market Wire

Unity Management Group, Inc, acquired Metropolitan Computer Corporation

synopsis: Unity Management Group, Inc announced that it has successfully completed the acquisition of Metropolitan Computer Corporation (MCC/ Legacy).
buyer: Unity Management Group, Inc (US:UYMG:$0.00)
Unity Management Group is a health resource company, which provides quality physician practice management services, that offer high value, and significant return, through its three subsidiary companies. United Healthcare Solutions, Unity Technologies Inc., and United Business Services. "
target: Metropolitan Computer Corporation
Metropolitan Computer Corporation (MCC/ Legacy) designs, engineers, markets, and services instrumentation equipment and software systems for increased efficiency within the pharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/31/2015 via PR Newswire

Nuvon, Inc. will be merged with Bernoulli Enterprise, Inc.,

synopsis: Cardiopulmonary Corp., a leader in real-time connected healthcare and Nuvon, a leader in medical device integration, interoperability, and clinical intelligence, announced that they have entered into a definitive agreement for Nuvon to merge with Cardiopulmonary Corp.
buyer: Bernoulli Enterprise, Inc.
Cardiopulmonary Corp. is a leader in real-time connected healthcare. Its flagship Bernoulli Enterprise system provides a platform for Medical Device Connectivity, Alarm Management, Virtual ICU and Analytics to enable better outcomes, reduce the cost of care and improve patient/staff satisfaction. "
target: Nuvon, Inc.
Nuvon's mission is to transform medicine by delivering critical Patient Care Data at the point of care. Nuvon's FDA cleared Class I and Class II Medical Device Connectivity and Clinical Intelligence Systems connect and automates the capture of Patient Care Data from medical devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2017 via BNC Analysis

B.Braun Medical Inc., acquired BPMpathway

synopsis: B. Braun, one of the world’s leading manufacturers of medical devices and pharmaceutical products, has acquired 270 Vision Limited (BPMpathway), a UK-based developer of wearable sensor technology. BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
buyer: B.Braun Medical Inc.
B. Braun is a German medical and pharmaceutical device company, which has offices and facilities in more than 50 countries. Its headquarters are located in the small town of Melsungen, in central Germany. "
target: BPMpathway
BPMpathway (270 Vision Limited) is a UK-based developer of wearable sensor technology. Product design and development company BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2013 via Market Watch

Medtronic, Inc., acquired CardioCom

synopsis: Medtronic, Inc., the global leader in medical technology, announced the closing of the acquisition of Cardiocom, a privately held developer and provider of integrated telehealth and patient services for the management of chronic diseases, in an all cash transaction valued at $200 million.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. "
target: CardioCom
Cardiocom is a proven leader in Integrated Clinical Telehealth Services. Cardiocom is a world-class developer, manufacturer and clinical telehealth solutions provider with cutting-edge, yet user-friendly telemonitoring products and services.
price ($mm)
$200
rev ($mm)
$50
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/24/2019 via BusinessWire

ZOLL Medical Corporation, acquired Mobilize RRS LLC

synopsis: ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has acquired Mobilize RRS LLC., a company that markets the Mobilize Rescue Systems app and associated rescue kits. Each Mobilize Rescue Systems product contains medical equipment that pairs with interactive software to help bystanders manage emergencies.
buyer parent: Asahi Kasei Group
buyer: ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. "
target: Mobilize RRS LLC
Mobilize RRS equips bystanders with the resources necessary to respond to medical emergencies. Mobilize RRS’ team of medical professionals, military veterans, and software developers integrated modern medical supplies and an innovative app into a cohesive unit, as Mobilize Rescue Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/15/2019 via BusinessWire

Tactical Medical Solutions, Inc., acquired TraumaFX

synopsis: Tactical Medical Solutions has acquired TraumaFX Solutions, Inc., a company that is dedicated to developing innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations.
buyer parent: Guardian Capital Partners
buyer: Tactical Medical Solutions, Inc.
Tactical Medical Solutions, LLC (TacMed) is a global leader in the development and manufacture of innovative, proprietary pre-hospital medical products and technologies that serve a full spectrum of emergency response environments. "
target parent: ManTech International Corporation
target: TraumaFX
TraumaFX is dedicated to developing innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/1/2017 via BusinessWire

Clayton, Dubilier & Rice, Inc., Hillhouse Capital, acquired Carestream Dental

synopsis: Carestream Health, working with its parent company, Onex Corporation, has completed the sale of Carestream’s dental digital business to funds managed by Clayton, Dubilier & Rice, a global private investment firm, and CareCapital, a specialist investment platform focused on dental and consumer health in Asia and part of Hillhouse Capital Management.
buyer: Clayton, Dubilier & Rice, Inc.
buyer: Hillhouse Capital
Founded in 1978, Clayton, Dubilier & Rice is a private investment firm. Since inception, CD&R has managed the investment of more than $22 billion in 72 companies representing a broad range of industries with an aggregate transaction value of more than $100 billion. "
target parent: Onex Corporation
target: Carestream Dental
Carestream Dental is the dental digital business of Carestream, an operating company of Onex Corporation. Carestream Dental provides digital imaging equipment and software solutions for dental and oral health professionals. They provide products that are used throughout the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/6/2012 via PR Newswire

CareFusion Corporation, will acquire PhACTs, LLC.

synopsis: CareFusion Corporation announced an agreement to acquire PHACTS, LLC, a Seattle-based technology and consulting company that helps hospital pharmacies better manage inventory, reduce pharmaceutical costs and streamline operations. Terms of the deal were not disclosed.
buyer: CareFusion Corporation (CFN:$3,598.00)
CareFusion Corporation is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. "
target: PhACTs, LLC.
PHACTS was formed to serve Health Systems with multiple hospitals and/or clinics, doctors' offices, surgery centers and other locations, which need to account for and provide medications and pharmacy supplies across their network.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Applied Maths


read more

Applied Maths

NextBio, Inc.

Mavens

SHYFT Analytics

Geospiza

Dotmatics

SnapGene

CollabRX, Inc

Jungla Inc.

Cytobank

BlueBee

Discovery Innovations, Inc.

Dropprint Genomics

Geneious

HealthLytix

CancerGene Connect

Bina Technologies

UNIConnect LC

read more

Applied Maths

read more

Applied Maths

read more

Apogent Technologies, Inc.

ERT

ERT

InTouch Health

Broadleaf Co., Ltd.

AAIPharma Services

Genaissance Pharmaceuticals, Inc.

Livongo

BreathResearch

ImPACT Concussion Management

Neuro Motor Innovations Corporation

Telcare

Metropolitan Computer Corporation

Nuvon, Inc.

BPMpathway

CardioCom

Mobilize RRS LLC

TraumaFX

Carestream Dental

PhACTs, LLC.

Geography
Matching Companies
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
bioMérieux S.A.
bioMérieux S.A.
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
year
2015
rev ($mm)
$1,996.55
EBITDA ($mm)
$404.73
EBIT ($mm)
$278.41
Net Income ($mm)
$155.44
Employees
9258
  • drill down
  • watch
Ticker: XTRA:SBS
 
 
 
 
 
 
 
 
Stratec SE
Stratec SE
STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers complex consumables for diagnostic and medical applications.
year
2019
rev ($mm)
$240.89
EBITDA ($mm)
$38.57
EBIT ($mm)
$21.94
Net Income ($mm)
$15.69
Employees
1223
  • drill down
  • watch
Ticker: ENXTPA:DIM
 
 
 
 
 
 
 
 
Sartorius AG
Sartorius AG
Sartorius is a international pharmaceutical and laboratory equipment supplier. With their innovative products and services, they are helping their customers across the entire globe to implement their complex and quality-critical biomanufacturing and laboratory processes reliably and economically.
year
2016
rev ($mm)
$1,121.72
EBITDA ($mm)
$299.20
EBIT ($mm)
$257.20
Net Income ($mm)
$163.92
Employees
4590
  • drill down
  • watch
Ticker: ABT
 
 
 
 
 
 
 
 
Abbott Laboratories
Abbott Laboratories
Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
year
2009
rev ($mm)
$30,764.71
EBITDA ($mm)
$8,220.25
EBIT ($mm)
$6,130.74
Net Income ($mm)
$5,745.84
Employees
73000
  • drill down
  • watch
Ticker: BDX
 
 
 
 
 
 
 
 
Becton, Dickinson and Company
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a leading medical technology company. BD’s innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research.
year
2020
rev ($mm)
$17,117.00
EBITDA ($mm)
$4,569.00
EBIT ($mm)
$2,415.00
Net Income ($mm)
$874.00
Employees
65000
  • drill down
  • watch
Ticker: SYK
 
 
 
 
 
 
 
 
Stryker Corporation
Stryker Corporation
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties.
year
2016
rev ($mm)
$10,062.00
EBITDA ($mm)
$2,717.00
EBIT ($mm)
$2,312.00
Net Income ($mm)
$1,617.00
Employees
27000
  • drill down
  • watch
Ticker: CAH
 
 
 
 
 
 
 
 
Cardinal Health, Inc.
Cardinal Health, Inc.
Cardinal Health, Inc. improves the cost-effectiveness of the health care industry. Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability.
year
2018
rev ($mm)
$141,935.00
EBITDA ($mm)
$2,870.00
EBIT ($mm)
$1,860.00
Net Income ($mm)
Employees
50200
  • drill down
  • watch
Ticker: FMS
 
 
 
 
 
 
 
 
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA
As a vertically integrated company, we offer products and services for the entire dialysis value chain. The highest medical standards are our benchmark.
year
2009
rev ($mm)
$11,247.48
EBITDA ($mm)
$2,212.68
EBIT ($mm)
$1,755.60
Net Income ($mm)
$891.14
Employees
72812
  • drill down
  • watch
Ticker: COV
 
 
 
 
 
 
 
 
Covidien
Covidien
Tyco Healthcare became Covidien and began independently trading on the New York and Bermuda Stock Exchanges on July 2, 2007, marking its debut as an independent diversified global healthcare products company.
year
2010
rev ($mm)
$10,429.00
EBITDA ($mm)
$2,628.00
EBIT ($mm)
$2,139.00
Net Income ($mm)
$1,632.00
Employees
41500
  • drill down
  • watch
Ticker: FAGR
 
 
 
 
 
 
 
 
Fagron
Fagron
Fagron is an innovative scientific pharmaceutical R&D company that is focused on optimising and innovating pharmaceutical compounding worldwide. Fagron offers Fagron Compounding Essentials, Fagron Trademarks and Fagron Compounding Services to pharmacies and hospital pharmacies in 30 countries.
year
2014
rev ($mm)
$473.30
EBITDA ($mm)
$113.50
EBIT ($mm)
$96.32
Net Income ($mm)
$17.17
Employees
1902
  • drill down
  • watch
Ticker: BABY
 
 
 
 
 
 
 
 
Natus Medical, Incorporated
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment and neurological dysfunction.
year
2014
rev ($mm)
$352.46
EBITDA ($mm)
$64.99
EBIT ($mm)
$54.44
Net Income ($mm)
$30.91
Employees
943
  • drill down
  • watch
Ticker: SGN
 
 
 
 
 
 
 
 
Signalife, Inc.
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring.
year
2007
rev ($mm)
EBITDA ($mm)
($14.36)
EBIT ($mm)
($14.46)
Net Income ($mm)
Employees
15
  • drill down
  • watch
Ticker: HAE
 
 
 
 
 
 
 
 
Haemonetics Corporation
Haemonetics Corporation
Haemonetics is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions. Their technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
year
2020
rev ($mm)
$988.48
EBITDA ($mm)
$266.02
EBIT ($mm)
$173.83
Net Income ($mm)
$76.53
Employees
3004
  • drill down
  • watch
Ticker: SPA
 
 
 
 
 
 
 
 
Sparton Corporation
Sparton Corporation
Sparton Corporation, now in its 115th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service, and refurbishment.
year
2014
rev ($mm)
$338.86
EBITDA ($mm)
$32.07
EBIT ($mm)
$23.21
Net Income ($mm)
$10.89
Employees
1385
  • drill down
  • watch
Ticker: BIOP
 
 
 
 
 
 
 
 
Riot Blockchain
Riot Blockchain uses its expertise and network to build and support blockchain technology companies. It is establishing an Advisory Board with technical experience intending to become a leading authority and supporter of blockchain, while providing investment exposure to the blockchain ecosystem.
year
2017
rev ($mm)
$0.01
EBITDA ($mm)
($5.25)
EBIT ($mm)
($5.49)
Net Income ($mm)
Employees
8
  • drill down
  • watch